- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- BMA: beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-BMA.2: 6 residues within 4Å:- Chain B: R.543, N.546, T.548, T.730, N.751
- Ligands: NAG-NAG.3
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:R.543
NAG-NAG-BMA-BMA.5: 5 residues within 4Å:- Chain D: R.543, N.546, T.548, T.730
- Ligands: NAG-NAG.6
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:R.543
- 4 x 2J9: 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide(Non-covalent)
2J9.7: 15 residues within 4Å:- Chain A: K.531, P.532, F.533, M.534, T.535, L.783, Q.786, L.791
- Chain D: I.519, P.532, M.534, T.535, S.761, K.762, G.763
4 PLIP interactions:2 interactions with chain D, 2 interactions with chain A- Hydrophobic interactions: D:P.532, A:T.535, A:L.791
- Halogen bonds: D:M.534
2J9.15: 14 residues within 4Å:- Chain A: I.519, P.532, M.534, T.535, S.761, K.762, G.763
- Chain D: K.531, P.532, F.533, M.534, T.535, L.783, Q.786
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain D- Hydrophobic interactions: A:P.532, D:T.535
- Halogen bonds: A:M.534
2J9.21: 14 residues within 4Å:- Chain B: K.531, P.532, F.533, M.534, T.535, L.783, Q.786
- Chain C: I.519, P.532, M.534, T.535, S.761, K.762, G.763
3 PLIP interactions:2 interactions with chain C, 1 interactions with chain B- Hydrophobic interactions: C:P.532, B:T.535
- Halogen bonds: C:M.534
2J9.24: 14 residues within 4Å:- Chain B: I.519, P.532, M.534, T.535, S.761, K.762, G.763
- Chain C: K.531, P.532, F.533, M.534, T.535, L.783, Q.786
3 PLIP interactions:2 interactions with chain B, 1 interactions with chain C- Hydrophobic interactions: B:P.532, C:T.535
- Halogen bonds: B:M.534
- 16 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
POV.8: 18 residues within 4Å:- Chain A: V.552, F.553, L.556, N.557, P.561, W.564, M.565, L.568, V.616, L.619, M.620, I.647, Y.651, V.826
- Chain D: I.639, F.642, L.645
- Ligands: POV.9
Ligand excluded by PLIPPOV.9: 13 residues within 4Å:- Chain A: V.552, F.553, L.568, L.572, W.613, V.616, A.829, L.833
- Chain D: L.631, R.634, I.635
- Ligands: POV.8, POV.35
Ligand excluded by PLIPPOV.10: 7 residues within 4Å:- Chain A: V.817, Q.818, I.825, L.831, V.832
- Chain D: Y.566, G.573
Ligand excluded by PLIPPOV.13: 15 residues within 4Å:- Chain A: L.631, R.634, I.635, I.639
- Chain B: L.609, F.612, W.613, I.825, V.826, A.829, G.830, L.833
- Ligands: POV.14, POV.22, POV.23
Ligand excluded by PLIPPOV.14: 8 residues within 4Å:- Chain A: Y.587
- Chain B: L.572, L.609, F.612, L.833, F.836
- Ligands: POV.13, POV.22
Ligand excluded by PLIPPOV.22: 19 residues within 4Å:- Chain A: G.638, I.639, F.642, L.645
- Chain B: P.550, G.551, F.553, S.554, L.556, W.564, V.567, L.568, V.616, L.619, M.620, I.648, V.826
- Ligands: POV.13, POV.14
Ligand excluded by PLIPPOV.23: 13 residues within 4Å:- Chain A: Y.566, G.573, C.576
- Chain B: N.549, V.552, V.817, Q.818, F.824, I.825, A.828, L.831, V.832
- Ligands: POV.13
Ligand excluded by PLIPPOV.25: 11 residues within 4Å:- Chain B: Y.587, I.635
- Chain C: L.608, L.609, F.612, L.833, F.836, G.840, E.841, Y.844
- Ligands: POV.28
Ligand excluded by PLIPPOV.27: 19 residues within 4Å:- Chain B: I.639, F.642, L.645
- Chain C: V.552, F.553, L.556, N.557, P.561, W.564, M.565, L.568, V.616, L.619, M.620, I.647, I.648, Y.651, V.826
- Ligands: POV.28
Ligand excluded by PLIPPOV.28: 17 residues within 4Å:- Chain B: L.631, R.634, I.635, G.638
- Chain C: V.552, F.553, L.568, L.572, L.609, F.612, W.613, V.616, I.825, A.829, L.833
- Ligands: POV.25, POV.27
Ligand excluded by PLIPPOV.29: 10 residues within 4Å:- Chain B: Y.566, G.573
- Chain C: V.817, Q.818, G.821, I.825, A.828, A.829, L.831, V.832
Ligand excluded by PLIPPOV.32: 7 residues within 4Å:- Chain C: Y.587
- Chain D: L.572, L.609, F.612, L.833, F.836
- Ligands: POV.37
Ligand excluded by PLIPPOV.35: 11 residues within 4Å:- Chain A: L.608, L.609, F.612, L.833, F.836, G.840, E.841, Y.844
- Chain D: Y.587, I.635
- Ligands: POV.9
Ligand excluded by PLIPPOV.36: 20 residues within 4Å:- Chain C: G.638, I.639, F.642, L.645
- Chain D: P.550, G.551, F.553, S.554, L.556, W.564, V.567, L.568, C.571, V.616, L.619, M.620, I.647, I.648, V.826
- Ligands: POV.37
Ligand excluded by PLIPPOV.37: 15 residues within 4Å:- Chain C: R.634, I.635
- Chain D: F.553, L.568, L.609, F.612, W.613, I.825, V.826, A.829, G.830, L.833
- Ligands: POV.32, POV.36, POV.38
Ligand excluded by PLIPPOV.38: 14 residues within 4Å:- Chain C: G.573, V.574, C.576, V.577
- Chain D: N.549, V.552, V.817, Q.818, F.824, I.825, A.828, L.831, V.832
- Ligands: POV.37
Ligand excluded by PLIP- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.11: 4 residues within 4Å:- Chain A: R.543, N.749, N.751
- Ligands: NAG-NAG.1
2 PLIP interactions:2 interactions with chain A- Hydrogen bonds: A:R.543, A:N.751
NAG.30: 4 residues within 4Å:- Chain C: R.543, N.749, N.751
- Ligands: NAG-NAG.4
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:R.543, C:N.751
- 2 x 6ZP: 2-(6'-oxo-1'-phenyl[1',6'-dihydro[2,3'-bipyridine]]-5'-yl)benzonitrile(Non-covalent)
6ZP.12: 16 residues within 4Å:- Chain A: N.549, P.550, S.554, F.555, N.557, P.558, Y.651, N.654, L.655, F.658, L.815, N.819
- Chain B: A.812, S.813, A.814
- Chain D: S.650
7 PLIP interactions:7 interactions with chain A- Hydrophobic interactions: A:P.550, A:F.555, A:N.557, A:L.655, A:L.655, A:F.658
- Hydrogen bonds: A:N.819
6ZP.31: 15 residues within 4Å:- Chain B: S.650
- Chain C: N.549, P.550, S.554, F.555, N.557, P.558, Y.651, N.654, L.655, F.658, L.659, L.815, N.819
- Chain D: A.812
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:P.550, C:F.555, C:N.557, C:P.558, C:L.655, C:L.655, C:F.658, C:F.658, C:F.658, C:F.658
- Hydrogen bonds: C:N.819
- 7 x NA: SODIUM ION(Non-functional Binders)
NA.16: 4 residues within 4Å:- Chain A: Q.621
- Chain B: Q.621
- Chain C: Q.621
- Chain D: Q.621
1 PLIP interactions:1 interactions with chain C- Hydrogen bonds: C:Q.621
NA.17: 2 residues within 4Å:- Chain A: T.652, A.656
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:T.652
NA.18: 7 residues within 4Å:- Chain A: A.656, T.660
- Chain B: A.656, T.660
- Chain C: A.656, T.660
- Chain D: T.660
5 PLIP interactions:1 interactions with chain B, 2 interactions with chain D, 1 interactions with chain C, 1 interactions with chain A- Hydrogen bonds: B:T.660, D:T.660, D:T.660, C:T.660, A:T.660
NA.19: 4 residues within 4Å:- Chain A: D.528, M.770, R.775
- Chain D: D.776
2 PLIP interactions:1 interactions with chain A, 1 interactions with chain D- Hydrogen bonds: A:R.775, D:D.776
NA.26: 4 residues within 4Å:- Chain B: E.524, I.527, D.528
- Chain C: I.780
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:E.524
NA.33: 4 residues within 4Å:- Chain B: D.776
- Chain C: D.528, M.770, R.775
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:D.528, C:R.775
NA.39: 4 residues within 4Å:- Chain A: I.780
- Chain D: E.524, I.527, D.528
1 PLIP interactions:1 interactions with chain D- Hydrogen bonds: D:D.528
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gangwar, S.P. et al., Positive and negative allosteric modulation of GluK2 kainate receptors by BPAM344 and antiepileptic perampanel. Cell Rep (2023)
- Release Date
- 2023-04-19
- Peptides
- Glutamate receptor ionotropic, kainate 2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- BMA- BMA: beta-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 4 x 2J9: 4-cyclopropyl-7-fluoro-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide(Non-covalent)
- 16 x POV: (2S)-3-(hexadecanoyloxy)-2-[(9Z)-octadec-9-enoyloxy]propyl 2-(trimethylammonio)ethyl phosphate(Non-covalent)
- 2 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x 6ZP: 2-(6'-oxo-1'-phenyl[1',6'-dihydro[2,3'-bipyridine]]-5'-yl)benzonitrile(Non-covalent)
- 7 x NA: SODIUM ION(Non-functional Binders)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Gangwar, S.P. et al., Positive and negative allosteric modulation of GluK2 kainate receptors by BPAM344 and antiepileptic perampanel. Cell Rep (2023)
- Release Date
- 2023-04-19
- Peptides
- Glutamate receptor ionotropic, kainate 2: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
D - Membrane
-
We predict this structure to be a membrane protein.